You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease

[Journal of Parkinson’s Disease, 9(3) (2019), 553–563, DOI 10.3233/JPD-191648]

On page 560, the following Disclaimer was missing from the published article:

The findings and conclusions in this publications by the authors from US Food and Drug Administration are those of the authors and do not necessarily represent the views of the FDA.